Ki-67, P53, BCL-2 and Bax Expression in Urothelial Carcinomas of Urinary Bladder

Turk Patoloji Dergisi - Turkey
doi 10.5146/tjpath.2010.00991
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Federation of Turkish Pathology Societies

Related search

The Diagnostic Role of P53 and Ki 67 Immunohistochemistry in Evaluation of Urinary Bladder Carcinomas in Egyptian Patients

International Journal of Chinese Medicine
2019English

Imp3 Expression in Urothelial Carcinomas of the Urinary Bladder

Turk Patoloji Dergisi
Forensic MedicinePathology
2011English

Imp3 Expression in Urothelial Carcinomas of the Urinary Bladder

Turk Patoloji Dergisi
Forensic MedicinePathology
2011English

Long Term Lithium Treatment Suppresses P53 and Bax Expression but Increases BCL-2 Expression

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

BCL-2 Over-Expression in Urothelial Tumors of the Bladder. An Immunohistochemical Study

Annals of the College of Medicine, Mosul
2018English

The Prognostic Significance of Serum CA125 Levels With ER, PR, P53 and Ki-67 Expression in Endometrial Carcinomas

Ginekologia Polska
GynecologyObstetrics
2019English

Immunohistochemical BCL-2 and Ki-67 Expression Predict Survival in Prostate Cancer Patients Followed Expectantly

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
1999English

P53 and Ki-67 Expression in Renal Cell Carcinomas of Pregnant Women and Their Correlation With Prognosis: A Pilot Study

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2008English

Ki-67 MIB1 Labelling Index and the Prognosis of Primary TaT1 Urothelial Cell Carcinoma of the Bladder

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy